ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102627; 2) Community: the network communities that were significantly associated with the response to NSC 102627; 3) Molecule: the relationships between components within communities and NSC 102627; 4) MDR: the compounds that were significantly associated with the NSC 102627.

NSC Compound Enrichment Correlation
NSC 145668 Cyclocytidine hydrochloride 0.00526022686151168 0.63321788
NSC 329261 Null 0.00526022686151168 0.16541847
NSC 337581 ROYLEANONE-7A-FORMYLOXY-6B-HYDROXY-ERU 701 0.00526022686151168 0.3778804
NSC 40273 Null 0.00526022686151168 0.28161808
NSC 606985 Camptothecin Derivative 0.00526022686151168 0.59967832
NSC 643001 3'O-phosphono-(Z)-combretastatin A-4, ammonium salt, hydrate [10:15:4] 0.00526022686151168 0.27169714
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.00526022686151168 -0.091307104
NSC 672215 Null 0.00526022686151168 0.41215935
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.00526022686151168 0.29687293
NSC 684440 Null 0.00526022686151168 0.65886458
Total:122  Current:19    [First] [Prev] [Next] [Last]